T-20 With Anti-HIV Combination Therapy for Patients With Prior Anti-HIV Drug Treatment and/or Drug Resistance to Each of the Three Classes of Approved Anti-HIV Drugs
Public ClinicalTrials.gov record NCT00008528. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase III Open-Label, Randomized, Active-Controlled Study Assessing the Efficacy and Safety of T-20 (HIV-1 Fusion Inhibitor) in Combination With an Optimized Background Regimen, Versus Optimized Background Therapy Alone, in Patients With Prior Experience and/or Prior Documented Resistance to Each of the Three Classes of Approved Antiretrovirals (Nucleoside Reverse Transcriptase, Non-Nucleoside Reverse Transcriptase and Protease Inhibitors)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to compare the change in viral load (amount of HIV in the blood) of patients who receive T-20 with selected anti-HIV drugs to that of patients who receive only selected anti-HIV drugs.
Study identification
- NCT ID
- NCT00008528
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 525 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 16 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Not listed
- Primary completion
- Not listed
- Completion
- Not listed
- Last update posted
- Jun 24, 2005
United States locations
- U.S. sites
- 34
- U.S. states
- 19
- U.S. cities
- 30
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Univ of Alabama at Birmingham | Birmingham | Alabama | 352942050 | — |
| Phoenix Body Positive | Phoenix | Arizona | 85006 | — |
| Pacific Oaks Med Group | Beverly Hills | California | 90211 | — |
| AIDS Healthcare Foundation | Los Angeles | California | 900276069 | — |
| Univ of California, San Diego | San Diego | California | 92103 | — |
| San Francisco Gen Hosp | San Francisco | California | 94110 | — |
| San Francisco VA Med Ctr | San Francisco | California | 94121 | — |
| Univ of Colorado Health Sciences Ctr | Denver | Colorado | 80262 | — |
| Whitman Walker Clinic/Elizabeth Taylor Med Ctr | Washington D.C. | District of Columbia | 20009 | — |
| IDC Research Initiative | Altamonte Springs | Florida | 32701 | — |
| Steinhart Medical Associates | Miami | Florida | 33133 | — |
| AIDS Research Consortium of Atlanta | Atlanta | Georgia | 30308 | — |
| Trevor Slom | Chicago | Illinois | 60611 | — |
| Indiana Univ Hosp | Indianapolis | Indiana | 462025250 | — |
| New England Med Ctr | Boston | Massachusetts | 02111 | — |
| Massachusetts Gen Hosp | Boston | Massachusetts | 02114 | — |
| Community Research Initiative of New England | Brookline | Massachusetts | 02445 | — |
| Regions Hosp | Saint Paul | Minnesota | 55101 | — |
| Albany Med College | Albany | New York | 12208 | — |
| Peter Tsang | New York | New York | 10011 | — |
| Columbia Presbyterian Med Ctr | New York | New York | 100323784 | — |
| Univ of North Carolina / SOCA | Chapel Hill | North Carolina | 275997030 | — |
| Univ of Cincinnati | Cincinnati | Ohio | 452670405 | — |
| Case Western Reserve Univ / AIDS Clinical Trials Unit | Cleveland | Ohio | 44106 | — |
| Oregon Health Sciences Univ | Portland | Oregon | 97201 | — |
| MCP Hahnemann Univ | Philadelphia | Pennsylvania | 19102 | — |
| Pennsylvania Oncology and Hematology Associates | Philadelphia | Pennsylvania | 19106 | — |
| Univ of Pittsburgh | Pittsburgh | Pennsylvania | 15213 | — |
| Vanderbilt Univ Med Ctr | Nashville | Tennessee | 37212 | — |
| Nicholas Bellos | Dallas | Texas | 75246 | — |
| Univ of Texas Med Branch | Galveston | Texas | 77555 | — |
| Univ of Texas / Thomas Street Clinic | Houston | Texas | 77030 | — |
| Univ of Washington / AIDS Clinical Trial Unit | Seattle | Washington | 98104 | — |
| Vancouver Clinic | Vancouver | Washington | 98664 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 3 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00008528, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 24, 2005 · Synced Oct 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00008528 live on ClinicalTrials.gov.